摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(11β)-9-Fluoro-11-hydroxy-17,17-bis(methylthio)androsta-1,4-dien-3-one | 68159-85-3

中文名称
——
中文别名
——
英文名称
(11β)-9-Fluoro-11-hydroxy-17,17-bis(methylthio)androsta-1,4-dien-3-one
英文别名
9-Fluoro-11β-hydroxy-17,17-bis(methylthio)androsta-1,4-dien-3-one;9-fluoro-11β-hydroxy-17,17-bis(methylthio)androsta-1,4-diene-3-one;ANDROSTA-1,4-DIEN-3-ONE, 17,17-BIS(METHYLTHIO)-9-FLUORO-11-HYDROXY-, (11-beta)-;(8S,9R,10S,11S,13S,14S)-9-fluoro-11-hydroxy-10,13-dimethyl-17,17-bis(methylsulfanyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(11β)-9-Fluoro-11-hydroxy-17,17-bis(methylthio)androsta-1,4-dien-3-one化学式
CAS
68159-85-3
化学式
C21H29FO2S2
mdl
——
分子量
396.59
InChiKey
KQBDCBFJWHSHIP-WVBSATCKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    534.8±50.0 °C(Predicted)
  • 密度:
    1.25±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    26
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    87.9
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:82981436d20c348f838f4b2a4a8818c5
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Selective thioketalization process, process for preparing thioenol ethers from thioketals, and process for the preparation of thioketals
    申请人:E.R. SQUIBB & SONS, INC.
    公开号:EP0524813A1
    公开(公告)日:1993-01-27
    A selective thioketalization process for the preparation of a thioketal from a dione where one, but not the other, keto group of the dione is α,β-unsaturated, and where selective thioketalization occurs at the keto group of the dione which is not α,β-unsaturated, comprising the step of contacting the dione with a thiol, in the presence of a protic acid catalyst which is a complex of a Lewis acid and a protic source, wherein the temperature of the reaction medium is maintained below about 25°C during the reaction. Preferably, further, (i) the acid catalyst is employed in excess and/or (ii) the thiol is employed in excess. The inventive process may be employed, for example, in the preparation of a 3-keto,17-thioketalandrostene from the corresponding 3,17-diketoandrostene. A process for the preparation of thioenolethers from thioketals, especially 3-keto,17-thioenoletherandrostenes from 3-keto,17-thioketalandrostenes, wherein the thioketal is contacted with a protic acid catalyst. A process for the preparation of thioketals, especially mixed thioketals such as mixed 3-keto,17-thioketalandrostenes, from thioenolethers, comprising the step of contacting a thioenolether with a thiol in the presence of a protic acid catalyst.
    一种选择性醚化过程,用于从二酮制备醚,其中二酮的一个但不是另一个酮基是α,β-不饱和的,选择性醚化发生在不是α,β-不饱和的酮基上,包括将二酮与醇接触,在存在Lewis酸和质子源的复合物的质子酸催化剂的情况下,反应介质的温度在反应过程中保持在大约25°C以下。最好,进一步,(i) 过量使用酸催化剂和/或 (ii) 过量使用醇。该创新过程可以用于从相应的3,17-二酮雄烯制备3-酮,17-醚雄烯。一种从醚制备烯醚的过程,特别是从3-酮,17-醚雄烯制备3-酮,17-烯醚雄烯的过程,其中醚与质子酸催化剂接触。一种从烯醚制备醚的过程,特别是从烯醚制备混合醚,例如混合的3-酮,17-醚雄烯,包括将烯醚与醇在质子酸催化剂的存在下接触的步骤。
  • 13-Alkylthio (and arylthio)-11,17-epoxy-17-methyl-18-norandrostenes
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04133811A1
    公开(公告)日:1979-01-09
    Steroids having the formula ##STR1## wherein X is --S--, ##STR2## R.sub.1 is alkyl or aryl; R.sub.2 is hydrogen or halogen; and R.sub.3 is hydrogen, fluorine or methyl; can be used as antiinflammatory agents.
    具有以下式子的类固醇可以用作抗炎药物:##STR1## 其中X为--S--, ##STR2## R.sub.1为烷基或芳基;R.sub.2为氢或卤素;R.sub.3为氢、或甲基。
  • 17-Alkylthio (and arylthio)-1',2',3',4'-tetrahydroandrosteno [16
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04091036A1
    公开(公告)日:1978-05-23
    pg,1 Steroids having the formula ##STR1## wherein X is ##STR2## R.sub.1 is alkyl, aryl or acyloxyalkyl; R.sub.2 and R.sub.3 are the same or different and are hydrogen, alkyl, alkoxy, carboalkoxy, formyl, ##STR3## hydroxy, halogen, phenyl or cyano, with the proviso that when R.sub.2 and R.sub.3 are different, one of R.sub.2 and R.sub.3 is hydrogen; R.sub.4 is carbonyl, .beta.-hydroxymethylene or .beta.-acyloxymethylene; R.sub.5 is hydrogen or halogen; and R.sub.6 is hydrogen or fluorine; can be used as antiinflammatory agents.
    具有以下式子的类固醇化合物可以用作抗炎药物:##STR1## 其中,X为##STR2## R.sub.1为烷基、芳基或酰氧基烷基;R.sub.2和R.sub.3相同或不同,可以是氢、烷基、烷氧基、羧烷氧基、甲酰基、##STR3## 羟基、卤素、苯基或基,但R.sub.2和R.sub.3不同时,其中一个为氢;R.sub.4为羰基、β-羟甲基或β-酰氧甲基;R.sub.5为氢或卤素;R.sub.6为氢或
  • 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions
    申请人:E.R. Squibb & Sons, Inc.
    公开号:EP0073026A1
    公开(公告)日:1983-03-02
    Described are 3-Ketoandrostenes having in the 17- position the substituents R,-S- and R2-S- wherein R, and R2 are the same or different and each is alkyl, cycloalkyl or aryl, which have antiinflammatory activity.
    所述的 3-酮雄烯在 17- 位具有取代基 R、-S- 和 R2-S-,其中 R 和 R2 相同或不同,且各自为烷基、环烷基或芳基,具有抗炎活性。
  • US4091036A
    申请人:——
    公开号:US4091036A
    公开(公告)日:1978-05-23
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B